soul trial oral semaglutide cardiovascular outcomes 2024 results nejm Semaglutide's Impact on Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial (NEJM 2025): Oral
Pay in 4 interest-free payments of $5.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23






















